Analysis of GII.P7 and GII.6 noroviruses circulating in Italy during 2011-2016 reveals a replacement of lineages and complex recombination history.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
11 2019
Historique:
received: 25 05 2019
revised: 01 08 2019
accepted: 02 08 2019
pubmed: 9 8 2019
medline: 22 4 2020
entrez: 9 8 2019
Statut: ppublish

Résumé

Noroviruses are important human enteric pathogens and monitoring their genetic diversity is important for epidemiological surveillance, vaccine development, and understanding of RNA viruses evolution. Epidemiological investigations have revealed that genogroup II, genotype 6 noroviruses (GII.6) are common agents of gastroenteritis. Upon sequencing of the ORF2 (encoding the viral capsid), GII.6 viruses have been distinguished into three variants. Sentinel hospital-based surveillance in Italy revealed that GII.6 noroviruses were the second most common capsid genotype in 2015, mostly in association with a GII.P7 ORF1 (encoding the viral polymerase). Upon molecular characterization of the ORF1 and ORF2, the GII.P7_GII.6 epidemic viruses circulating in 2014-2015 (variant GII.6b) were different from those that circulated sporadically in 2011-2013 (variant GII.6a). Analysis of the ORF1 (GII.P7) and ORF2 (GII.6) sequences available in the databases unveiled marked genetic diversity and peculiarities in the phylogenetic segregation patterns, suggesting multiple recombination events. Phylogenetic analyses suggest that recent GII.P7_GII.6b viruses were circulating as early as 2008, and formed a genetically homogenous group that emerged globally.

Identifiants

pubmed: 31394293
pii: S1567-1348(19)30209-6
doi: 10.1016/j.meegid.2019.103991
pii:
doi:

Substances chimiques

Capsid Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103991

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Georgia Diakoudi (G)

Dipartimento di Medicina Veterinaria, Università Aldo Moro di Bari, Italy.

Gianvito Lanave (G)

Dipartimento di Medicina Veterinaria, Università Aldo Moro di Bari, Italy.

Cristiana Catella (C)

Dipartimento di Medicina Veterinaria, Università Aldo Moro di Bari, Italy.

Maria Cristina Medici (MC)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Italy.

Flora De Conto (F)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Italy.

Adriana Calderaro (A)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Italy.

Daniela Loconsole (D)

Dipartimento di Scienze Biomediche e Oncologia Umana, Università Aldo Moro di Bari, Italy.

Maria Chironna (M)

Dipartimento di Scienze Biomediche e Oncologia Umana, Università Aldo Moro di Bari, Italy.

Floriana Bonura (F)

Dipartimento di Medicina Veterinaria, Università Aldo Moro di Bari, Italy.

Giovanni Maurizio Giammanco (GM)

Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", Università di Palermo, Italy.

Kristián Bányai (K)

Institute for Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of Sciences, Budapest, Hungary.

Kentaro Tohma (K)

Division of Viral Products, Food and Drug Administration, Silver Spring, MD, USA.

Gabriel Ignacio Parra (GI)

Division of Viral Products, Food and Drug Administration, Silver Spring, MD, USA.

Vito Martella (V)

Dipartimento di Medicina Veterinaria, Università Aldo Moro di Bari, Italy. Electronic address: vito.martella@uniba.it.

Simona De Grazia (S)

Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", Università di Palermo, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH